Cipher Pharmaceuticals Inc.
CPHR
CPHR was delisted on the 8th of December, 2016.
18 hedge funds and large institutions have $27.3M invested in Cipher Pharmaceuticals Inc. in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 3 closing their positions.
14% less funds holding
Funds holding: 21 → 18 (-3)
33% less capital invested
Capital invested by funds: $40.8M → $27.3M (-$13.5M)
56% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 9
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$12.4K |
| 2 |
Creative Planning
Overland Park,
Kansas
|
+$9.11K |
| 3 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$8.66K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Raffles Associates
New York
|
-$2.34M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$690K |
| 3 |
GPGA
Grandeur Peak Global Advisors
Salt Lake City,
Utah
|
-$150K |
| 4 |
AIC
AWM Investment Company
New York
|
-$118K |
| 5 |
IIM
Intact Investment Management
Montreal,
Quebec, Canada
|
-$91.1K |
CPHR Hedge Fund Activity: Q3 2016 in Review
18 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Cipher Pharmaceuticals Inc. (CPHR) for Q3 2016, worth a combined $27.3M — down 33% from $40.8M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CPHR and 0 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 4 added.
The largest buyer was Deutsche Bank, adding an estimated $12.4K. The largest seller was Raffles Associates, exiting entirely with an estimated $2.34M sold.
- 18 institutional investors held Cipher Pharmaceuticals Inc. (CPHR) as of Q3 2016, down from 21 in Q2 2016.
- Funds reported $27.3M of Cipher Pharmaceuticals Inc. stock for Q3 2016, down 33% quarter-over-quarter.
- 0 funds opened new Cipher Pharmaceuticals Inc. positions in Q3 2016 and 3 closed out, a net change of -3 holders.
- The largest Cipher Pharmaceuticals Inc. buyer in Q3 2016 was Deutsche Bank, an estimated $12.4K added.
- The largest Cipher Pharmaceuticals Inc. seller in Q3 2016 was Raffles Associates, an estimated $2.34M sold.
Based on aggregated 13F filings for Q3 2016.